Peer-influenced content. Sources you trust. No registration required. This is HCN.
MDLinx
A young child with an inherited tumor-predisposition syndrome develops recurrent bilateral visual decline after completing first-line chemotherapy for a radiographically diagnosed optic pathway tumor, requiring reassessment of treatment urgency, systemic options, and surveillance.
Medical Genetics October 19th 2026
A systematic review and meta-analysis linked plasma exchange with high recovery rates in MOGAD attacks, especially optic neuritis. Included studies were observational and could not isolate PLEX effects.
Emergency Medicine August 4th 2026
MDSpire News
A Swedish register-based cohort associated GLP-1 receptor agonist use with higher relative risk of anterior ischemic optic neuropathy. Absolute event rates were low, and findings attenuated after diabetes-severity controls.
Endocrinology, Diabetes, Metabolism August 4th 2026
Glaucoma Today
OCT, B-scan ultrasound, and ultrasound biomicroscopy identified distinct structural signatures across hypotony sequelae including maculopathy, choroidal detachment, and cyclodialysis cleft in cases where slit-lamp examination and indirect ophthalmoscopy alone proved insufficient.
Neuro-Ophthalmology June 15th 2026
Ophthalmology Advisor
Peripapillary hyperreflective ovoid mass-like structures showed no significant correlation with intracranial pressure levels in a cross-sectional cohort of 54 patients with idiopathic intracranial hypertension, suggesting anatomic rather than pressure-driven origins.
Neurology June 15th 2026
Retinal Physician
A retinal specialist reviewing GLP-1 ocular safety evidence at the Retina World Congress concluded that current data do not support withholding therapy based on ocular risk alone, while recommending baseline retinal examination and closer monitoring in patients with preexisting severe diabetic retinopathy.
Ophthalmology June 1st 2026